EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. - Wikidata - wikimedia - TriplyDB

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

http://www.wikidata.org/entity/Q35145144

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas Biomarkers for glioma immunotherapy: the next generation EGFR Amplification and Glioblastoma Stem-Like Cells Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.Strategies to genetically engineer T cells for cancer immunotherapy.History and current state of immunotherapy in glioma and brain metastasis.Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.Epidermal growth factor receptor and variant III targeted immunotherapy.Immunotherapy for malignant glioma Emerging immunotherapies for glioblastoma Immunotherapy in glioblastoma: emerging options in precision medicine Prioritization schema for immunotherapy clinical trials in glioblastoma.Chimaeric antigen receptor T-cell therapy for tumour immunotherapy.Chimeric antigen receptor T cells: a novel therapy for solid tumors.Immunotherapeutic advancements for glioblastoma.ErbB-targeted CAR T-cell immunotherapy of cancer.Glioblastoma antigen discovery--foundations for immunotherapy.Stem cell in alternative treatments for brain tumors: potential for gene delivery.CAR T-cell immunotherapy: The path from the by-road to the freeway?Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.Engineered T cells: the promise and challenges of cancer immunotherapy.Developing immunotherapeutic strategies to target brain tumors.Improving vaccine efficacy against malignant glioma Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Immunotherapy approaches in the treatment of malignant brain tumors.Immune and viral therapies for malignant primary brain tumors.Insights into molecular therapy of glioma: current challenges and next generation blueprint Safety of Intra-Arterial Injection With Tumor-Activated T Cells to the Rabbit Brain Evaluated by MRI and SPECT/CT.Biomarkers and therapeutic advances in glioblastoma multiforme.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.Targeting Malignant Brain Tumors with Antibodies.CD70, a novel target of CAR T-cell therapy for gliomas.Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors

P2860

Q26740520-E96391F0-8153-4CF9-8F25-1FAA51D2BE78 Q26825496-CD2A3E32-CAB5-4D6F-B6F3-F962A54B81D5 Q26853549-918B188B-8D27-4C95-BE44-CAA3332EE90A Q28082016-E3B24513-64F4-452C-8956-40BD31D4FEE5 Q33655849-F8EF411B-C7DF-4542-813A-3495DEB72E70 Q33656811-BF62FC0D-30C4-4B2B-8A09-CA12A11966F9 Q33721106-A5BC306C-D98A-4EF2-80D8-8198840BD54E Q34391942-B8B4DE68-DC07-4ACE-91FF-5B5CF9771DE9 Q35114086-DCA004D5-A2C5-46FA-9A85-67CCAF3DCF58 Q37025105-DA436E08-23D7-435A-BFF9-809554E79A90 Q37050960-DDCE9876-0F8A-4F5B-A0D5-BB13D5D76139 Q37078999-E83CA41D-F30B-4DCA-94CA-144B912470F3 Q37609801-084AB76A-A571-4E4E-9AD0-5845943385A1 Q37728639-CC6719B2-8CCB-4510-91AB-80E29F7FD524 Q38358124-C7A05643-5864-4DAD-9830-4367F3A80BE8 Q38389298-9374CCC6-EABB-4278-B170-E83EDA0D1D68 Q38516823-D7AC1357-D223-45B0-916B-91ED617A208F Q38521752-38972CDB-89BC-4297-B5A5-3433FD8058AA Q38632105-C491A1F4-4F56-427E-A334-68FAFB0999AC Q38770555-1A287C2E-4E13-434D-B886-D4415CDF2C36 Q38828829-033DA7FB-2523-498A-AA1A-0681D777A565 Q38851464-38BB79DA-995A-4234-9898-41854F63FE46 Q38953024-C736E745-8806-404D-857D-8F55C473F9FA Q38987239-28D27C27-FDBB-4596-A71E-7E1AD4D70F95 Q39016790-1A5268EB-C8DB-483C-816B-C5B7A3EDD766 Q39168899-F55F7593-3450-4579-B0E5-E89C9DE6CAB8 Q39187306-063A286B-3A89-4357-9693-4DD970762B9C Q39304787-58AE8C36-6006-49BF-8B2E-9B1C3CD37568 Q40070524-FF8E1C00-03F4-4ED7-8A61-FFB1D4BC0829 Q40089704-9AB2458C-3D7C-4963-9641-1C1D0D9614F5 Q42057942-346FB210-0015-496D-ACED-325418505791 Q42267793-8F11A781-C56A-42D7-9B63-F144D472EC6F Q48223703-22716E1D-9FE3-44EE-84A6-0F4F449C6F87 Q55383661-30F3B94F-0793-4C32-B6BC-CEC27861062D Q55457493-99B7D403-F432-4B26-B2D6-E7CA8DE134CF Q57300937-6B82CDCA-BA4C-4DBD-AED1-8C942A69C130 Q58606449-689F90E8-BA06-40C9-914C-020A646E1022

P2860

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

http://www.wikidata.org/entity/Q35145144

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@ast

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@en

type

label

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@ast

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@en

prefLabel

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@ast

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@en

P1433

Q35145144-1F229435-500A-4BBC-926A-5B12F059BC78

P1476

Q35145144-B94D16B1-B0C3-4FB7-9F29-A6F88C12D2CC

P2093

Q35145144-3ADBCAB5-07C2-4E4F-BD66-85CACC051DCB

Q35145144-43C3FC1D-4C8F-4C1C-B32B-2DE9DCAD3163

Q35145144-4996FB17-D7E6-4FFB-BEEB-CEA7118A347C

Q35145144-55252BAD-5CA0-4AC9-A53C-74732A746829

Q35145144-61E74FC1-A653-49B3-9A10-9C7212C28885

Q35145144-71ABE057-29CE-43C7-94FE-C277FB0AAB3F

Q35145144-954CA012-9089-4EA9-BEE3-02460D5A7CB8

Q35145144-987FDB2B-3B4F-4017-A40F-D89B68D101DB

Q35145144-C3327CB7-74A4-4130-96E8-4E36CD9DB16A

Q35145144-C9D24CEB-F530-4B60-B725-F673A36D8BF2

P2860

Q35145144-151F7245-D9DD-45EF-8DAF-ECBD17188BBD

Q35145144-18B4A48F-C3C5-4D3A-A361-3000A4049EEC

Q35145144-1B66E31F-9DF1-40DA-9BDF-CCA481629A89

Q35145144-2FA8C846-4145-4521-8716-DFBEC41A174E

Q35145144-4409EA6A-620F-42D8-BEB8-DB4B099BD8F0

Q35145144-45076140-E4C4-41BF-A2C0-E39A0F3360D3

Q35145144-45E86D17-41BB-4A10-A646-73A9F7FB7BEE

Q35145144-496F9D4F-727F-4A4E-84B7-53580BA6582E

Q35145144-4DC24B39-A7B9-47C5-B387-23D833D640FF

Q35145144-5A1A9A99-0411-4ABA-8B44-50D449B59B00

P304

Q35145144-04060238-74F3-4235-B6C2-595341508B61

P31

Q35145144-1BB2BD14-528A-44B5-ACE4-51265703A357

P356

Q35145144-C5010672-DA14-44CE-A016-9DB4A2396CD2

P407

Q35145144-D404BDEC-D307-4007-BB36-51DF65B909C7

P433

Q35145144-7F37DDF1-836B-4A25-BEBD-2D1B24618BD3

P478

Q35145144-40CC7F20-AF70-4DB4-A987-1845D981F42E

P50

Q35145144-BA1FA96B-624A-49D0-953F-AE989177617A

Q35145144-ECECF359-3804-4A6D-B131-D805BE840F2F

P577

Q35145144-34F6E01C-39BD-4FFF-9F80-6D75EE94459C

P5875

Q35145144-3D68F06D-FD2F-43EE-BCD6-6854D3E36639

P698

Q35145144-A284A053-E40B-4F74-9D24-B3006ABA1D3E

P921

Q35145144-8A69D046-9076-4DFF-AF9C-5A150BFEA67C

P932

Q35145144-AC62F0A9-1D30-495C-A828-8ECCBC251A6F

P356

JOURNAL.PONE.0094281

P1433

P1476

EGFRvIII-specific chimeric ant ...... nograft model of glioblastoma.

@en

P2093

Bryan D Choi

http://www.w3.org/2001/XMLSchema#string

Carter M Suryadevara

http://www.w3.org/2001/XMLSchema#string

Elias J Sayour

http://www.w3.org/2001/XMLSchema#string

Gabriel De Leon

http://www.w3.org/2001/XMLSchema#string

Gary E Archer

http://www.w3.org/2001/XMLSchema#string

Hongsheng Miao

http://www.w3.org/2001/XMLSchema#string

James E Herndon

http://www.w3.org/2001/XMLSchema#string

John H Sampson

http://www.w3.org/2001/XMLSchema#string

Laura A Johnson

http://www.w3.org/2001/XMLSchema#string

Luis Sanchez-Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Of mice and not men: differences between mouse and human immunology

Cancer despite immunosurveillance: immunoselection and immunosubversion

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

P304

e94281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0094281

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Darell D. Bigner

Roger E McLendon

P577

2014-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261603651

http://www.w3.org/2001/XMLSchema#string

P698

24722266

http://www.w3.org/2001/XMLSchema#string

P921

P932

3983153

http://www.w3.org/2001/XMLSchema#string